Medinova Diagnostic Services Board of Directors
Get the latest insights into the leadership at Medinova Diagnostic Services. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Dr. Sura Surendranath Reddy | Chairman & Non-Exe.Director |
| Mr. Sunil Chandra Kondapally | Managing Director |
| Mrs. B Vishnu Priya Reddy | Non Executive Director |
| Mr. P Kamalakar Rao | Independent Director |
| Mr. K Ravi Kumar Reddy | Independent Director |
Medinova Diagnostic Services Share price
MEDINOV
41.76
0.82 (2.00%)Last updated on 4 Sep, 2025 | 14:12 IST
BUYSELL
Today's High
42.40
Today's Low
41.31
52 Week Low
32.10
52 Week High
46.92
The current prices are delayed, login to your account for live prices
LoginMedinova Diagnostic Services FAQs
The board at Medinova Diagnostic Services consists of experienced professionals, including Dr. Sura Surendranath Reddy , Mr. Sunil Chandra Kondapally , and others, overseeing the company’s strategic and corporate governance.
Directors at Medinova Diagnostic Services are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Dr. Sura Surendranath Reddy is the current chairman at Medinova Diagnostic Services.
Executive directors at Medinova Diagnostic Services are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Medinova Diagnostic Services adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Medinova Diagnostic Services, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.